FDA Inspection 1257703 — Sun Pharma Canada Inc.
The FDA completed an inspection of Sun Pharma Canada Inc. on September 20, 2024 in Brampton. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 20, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Brampton (Canada)
Additional Details
Bioanalytical BA/BE